- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01900847
Ketamine and Morphine Versus Morphine Alone for the Treatment of Acute Pain in the Emergency Department
Our goal is to study whether giving people low dose ketamine along with morphine when they come to the Emergency Department will help their pain more than giving morphine by itself. There have been many studies showing that low dose ketamine is safe and effective for pain control. Ketamine is frequently used for pain control in ambulances and helicopters transporting injured patients to the hospital and has also been used for pain control in people who have just had surgery. The investigators would like to see if low dose ketamine would be safe and effective for patients with pain in the Emergency Department.
Patients are eligible for the study if they come to the Emergency Department and their treating physician decides to treat them with morphine (with certain exceptions such as pregnant patients and patients with eye injuries). They will be given information about participating in the study and if they agree, they will be given the study drug. The study drug will be either ketamine or salt water (saline). If patients continue to be in pain they will continue to receive doses of morphine just as they would if they were not in the study. If the treating physician feels that morphine alone is not enough, they will be free to choose another pain medication as they would normally.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Matthew Berkman, MD
- Phone Number: (520) 626-5510
- Email: mberkman@aemrc.arizona.edu
Study Locations
-
-
Arizona
-
Tucson, Arizona, United States, 85724
- University of Arizona Health Network University Campus 1501 North Campbell Ave
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Presenting to Emergency Department in acute pain
- age 18 and over
- determined to require morphine for pain control by treating physician
Exclusion Criteria:
- Patients presenting with headache or head injury
- Patient with eye injury or eye pain
- Nontraumatic chest Pain
- Pregnant patients or women of childbearing potential
- Patients allergic to morphine or ketamine
- Patients with known history of narcotic/alcohol abuse or presenting for narcotic medication refill
- Patients with hypertension: diastolic blood pressure > 100 OR systolic blood pressure > 180
- Patient whose pain is so severe that they are unable to give informed consent
- Patients who have had bad experiences to prior hallucinations from any origin
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Morphine and placebo
Patient's will receive morphine during the usual course of their emergency department care and will receive a saline in a volume equivalent to the ketamine administered in the experimental arm of the stuy
|
Dosage of morphine determined by treating physician
saline of same volume as appropriate weight based dose of ketamine
|
Experimental: Morphine and Ketamine
Patient's will receive a 0.3mg/kg dose of ketamine in addition to morphine given in the usual course of emergency department care
|
Dosage of morphine determined by treating physician
0.3mg/kg ketamine
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Numeric Pain Score
Time Frame: Baseline (zero minutes), 30 minutes and 1 hour after receiving study drug
|
Pain 0-10 with 0 being no pain and 10 being the worst pain
|
Baseline (zero minutes), 30 minutes and 1 hour after receiving study drug
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Total Amount of Morphine and Other Pain Medications Administered
Time Frame: Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
|
Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
|
Number of Participants With Adverse Events
Time Frame: Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
|
Data collected from the duration of the patient's Emergency Department stay (expected average 5 hours)
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Berkman, M. R., Larsen, J., Smith, J., Caldwell, J., Waterbrook, A., Stolz, U., & Denninghoff, K. (2014). 369 Ketamine and Morphine versus Morphine Alone for Treatment of Acute Pain in the Emergency Department. Annals of Emergency Medicine, 64(4), S131-S132.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Pain
- Neurologic Manifestations
- Disease Attributes
- Emergencies
- Acute Pain
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Peripheral Nervous System Agents
- Analgesics
- Sensory System Agents
- Anesthetics, Dissociative
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Excitatory Amino Acid Antagonists
- Excitatory Amino Acid Agents
- Analgesics, Opioid
- Narcotics
- Ketamine
- Morphine
Other Study ID Numbers
- 13-0045
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Pain
-
Rajavithi HospitalCompletedTotal Abdominal Hysterectomy ,Pain , Acute Postoperative,Gabapentin , CelecoxibThailand
-
Schulthess KlinikNot yet recruiting
-
Seoul National University HospitalNot yet recruiting
-
Chung-Ang University Gwangmyeong HospitalRecruitingPostoperative Pain, AcuteKorea, Republic of
-
TC Erciyes UniversityCompletedPostoperative Pain, AcuteTurkey
-
Zagazig UniversityRecruiting
-
Mansoura UniversityRecruitingPostoperative Pain, AcuteEgypt
-
University of California, San DiegoActive, not recruitingPostoperative Pain, AcuteUnited States
-
Umraniye Education and Research HospitalNot yet recruiting
-
Sohag UniversityCompletedPostoperative Pain, AcuteEgypt
Clinical Trials on Morphine
-
Indiana UniversityCompletedNeonatal Abstinence Syndrome | Neonatal Opioid Withdrawal Syndrome | Neonatal Opioid WithdrawalUnited States
-
Javelin PharmaceuticalsCompleted
-
Javelin PharmaceuticalsCompletedPain, PostoperativeUnited States
-
University of MonastirCompletedTitrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings (TIMORNEB)Acute Pain | Post-Traumatic HeadacheTunisia
-
Mahidol UniversityCompletedLung Diseases | Solitary MassThailand
-
University of Colorado, DenverCompletedScoliosis | Pain Management | Spinal FusionUnited States
-
Javelin PharmaceuticalsCompletedPost-Operative Pain | Third Molar Extraction
-
Cukurova UniversityCompleted
-
University College Hospital GalwayCompletedPain, Postoperative | Arthroplasty, Replacement, Knee
-
Rijnstate HospitalCompletedTotal Hip Replacement